Safety and Efficacy of Express LD to Treat Stenosed or Occlusive Atherosclerotic Disease in Iliac Arteries

Clinical trial NCT00352222 · COMPLETED

Trial details

NCT number: NCT00352222
Sponsor: Boston Scientific Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Arterial Occlusive Disease Intermittent Claudication Atherosclerotic Disease Thrombosis

Start date: 2004-01-01
Primary completion: 2005-07-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.